GE HealthCare Stock Soars After Earnings. Here's What Drove the Profit Gains. -- Barrons.com
Dow Jones2026/07/29 11:29By Al Root
GE HealthCare Technologies stock jumped after the company reported better-than-expected second-quarter earnings. Investors can breathe a sigh of relief amid a difficult year.
GE HealthCare on Wednesday announced earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 and $5.3 billion, respectively. A year ago, GE HealthCare reported earnings per share of $1.06 from sales of $5 billion.
Profit margins were better than expected and improved from first- quarter levels.
For 2026, GE HealthCare maintained guidance. It still expects sales growth of about 3.5% and earnings per share of about $4.90. Wall Street projects sales growth of more than 5%, but that figure includes foreign-currency benefits. Analysts project earnings per share of $4.88.
Shares were up 13% at $72.50 in premarket trading, while SP 500 and Dow Jones Industrial Average futures were up 0.2% and down 0.3%, respectively.
Orders helped too. Comparable orders grew 11.1% year over year, and orders exceeded quarterly revenue. The company's backlog is up to $23.9 billion.
"We delivered record orders and backlog in the second quarter, with [order] growth across every segment," said CEO Peter Arduini in a news release. "Our continued investment in precision innovation is expanding our addressable markets, strengthening our competitive position and supporting durable short- and long-term growth."
Earnings are a relief. Coming into Wednesday trading, GE HealthCare stock was down more than 20% year to date.
Falling earnings growth has been a big reason. At the start of the year, analysts projected earnings per share of nearly $5. Higher costs for everything, including memory chips, have weighed on results.
Write to Al Root at allen.root@barrons.com
This content was created by Barron's, which is operated by Dow Jones Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 29, 2026 07:29 ET (11:29 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin's Weirdest Trader Yet? Fly Brain Makes a Profit
Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street -- WSJ
NASDAQ TRADE HALT CONTINUES <MAMK.O> REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM